About Us

Welcome to Ideas & Solutions!

Ideas & Solutions is a boutique health policy and market access advisory group. We support pharmaceutical and medical device companies in developing market access strategies, positioning products in pricing and reimbursement systems, price-setting, as well as overcoming hurdles in pricing, reimbursement and health technology assessment (HTA).

Our story started in 2010 in Budapest, Hungary after the founders of Ideas & Solutions, Márk Molnár and Dávid Dankó, had spent a couple of exciting years in academia as health policy researchers and in pharmaceutical policy as payers and decision-makers. What was originally meant to be an interesting add-on to their academic career soon outgrew initial plans and soon Ideas & Solutions would become one of the most reputable strategy-focused pharmaceutical consulting groups in Central and Eastern Europe.

By 2015, our geographical scope covered the Middle East, North Africa and Central Asia, and we also went downstream by offering health economics and HTA services in some key markets. In the last couple of years, we have been increasingly working with global clients on high-impact policy projects, many of these focused on European Union member states.

Despite our dynamic growth we are still a lean, flexible team with a broad, multicultural mindset and a hands-on approach. Our clients appreciate the out-of-the-box ideas and the pragmatic solutions we proffer. The deep knowledge of payer mindsets, processes and organisations is instrumental to our success, and we are proud to rely on a network of exceptional experts across Europe and the world, most of them former policymakers or successful pharmaceutical executives.

Our Team

Dávid Dankó, PhD, MSc

Dávid Dankó is co-founder and managing partner of Ideas & Solutions (I&S), an independent consultancy group which provides strategic health policy and market access advisory to pharma and medical device companies with a focus on emerging and middle-income markets. Dávid has 20 years of experience in health care management & the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as deputy director of reimbursement at the national health insurance fund. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities and he has co-edited a university textbook titled ‘Pharmaceutical Reimbursement’. His research focuses are 1) linking managed entry agreements to value assessment of pharmaceuticals, 2) negotiations with payers and governmental stakeholders, 3) alternative payment models for pharmaceuticals. Dávid has lectured at the European Market Access University Diploma (EMAUD) programme, the Semmelweis University of Budapest, Debrecen University, Eötvös Loránd University and the former Vienna School of Clinical Research. He graduated in Economics from Corvinus University of Budapest and earned a PhD degree in 2012 with his thesis on long-term resource management in the pharmaceutical industry. Dávid has native/bilingual proficiency in English, Hungarian and Italian, full professional working proficiency in German, Portuguese and French, and professional working proficiency in Russian and Spanish.

Márk Molnár, PhD, MD, MSc

Márk Péter Molnár is co-founder and partner at Ideas & Solutions. He graduated from Semmelweis Medical University of Budapest and the University of West Hungary in 2005 in medical science (MD) and economics (MSc), respectively. In 2016, he earned his PhD degree at the Corvinus University of Budapest with his thesis on the drivers of patients’ adherence to medication and the long-term cost-effectiveness of improving patient adherence. From 2005 to 2006, he was engaged as health economist with the Hungarian Office for Health Technology Assessment. From 2006, he led the Pharmaceutical Department of the Hungarian National Health Insurance Fund (NHIFA). In 2008, he was appointed head of the Reimbursement Department at NHIFA and his responsibilities were extended to cover medical devices, too. In his consulting role, Márk’s focuses are: funding systems for middle-income and emerging markets; communication strategies between payers, key opinion leaders and pharmaceutical industry; and innovative business models for pharmaceutical companies. Márk is a regular speaker at international conferences and he has authored or co-authored several articles published in Hungarian and international journals. Márk has native/bilingual proficiency in English and Hungarian

Nóra Páll, MSc

Nóra Páll is senior project manager at Ideas & Solutions. She joined the team in 2013 and is currently responsible for managing our landscaping and market access strategy development projects across Europe. Nóra is also in charge of the Ideas & Solutions expert network across Central and Eastern Europe. She earned her MSc degree in health care policy, planning and financing with a specialization in health economics. In 2013, Nóra joined the Department of Biological Physics at Eötvös Loránd University, Budapest, Hungary, as a part-time researcher, deep-diving into network analysis of health care data (e.g monitoring pharmaceutical consumption patterns, patients’ pathways in rare diseases).

Elizaveta Popova, MSc

Elizaveta Popova is senior project manager at Ideas & Solutions, with responsibility for our projects and stakeholder management in Central and Eastern Europe and Central Asia. Before joining Ideas & Solutions in 2014, Elizaveta had gained a thorough understanding of Central and Eastern European health care markets as marketing manager for the institutional and reimbursed health care portfolio of SCA Hygiene Products (currently: Essity), and later as marketing director of a Swiss-based focusing on technology transfers of pharmaceutical and medical devices between Russia and German-speaking Europe. Elizaveta holds a MSc degree in international economics from the Russian University of Cooperation in Moscow. She possesses a sound multi-cultural experience and connects effectively with different stakeholders in different countries. Elizaveta has native/bilingual proficiency in Russian and English, and professional working proficiency in Hungarian.

Balázs Gáti, MSc

Balázs Gáti joined Ideas & Solutions as health economist in 2017. He earned his MSc degree at the Corvinus University of Budapest in management studies and international business. With his analytical skills, Balázs is instrumental in health economics and HTA projects of Ideas & Solutions and is the primary contact point for disease burden analyses, budget impact modelling. Recently, Balázs has added medical devices to his consulting portfolio and managed complex pricing & reimbursement (P&R) policy projects for industry associations in this segment, delivering widely cited White Papers.

Gábor Takács

Gábor Takács is a health economics and modelling expert at Ideas & Solutions. He graduated from the University of Miskolc in Hungary with a degree in Economics. After working in the field of economic statistics and specialized translation, he joined the Health Technology Assessment Office of Hungary as a health economist in 2013. In that role, he was involved in the critical evaluation of health technologies and economic models. From 2018 to 2021, he worked as a health economics analyst at Celltrion Healthcare, a biotherapeutics company, mainly on modelling projects. He has been a member of the Ideas & Solutions team since 2023, focusing on cost-effectiveness and budget impact analyses.

Ágnes Tóth, MA

Ágnes Tóth is senior researcher at Ideas & Solutions. She is engaged primarily in policy projects in health care pricing, funding (reimbursement) and value assessment, market access concepts and disease burden analysis. Ágnes earned her Master degree in sociology at the University of Szeged, Hungary. In 2009, she joined the Health Insurance Supervisory Authority. She was responsible for data collection and analysis on the national hospital quality indicator system, and annual reporting on the Hungarian health insurance system. In 2012 and 2013, she was member of the multi-stakeholder team which evaluated the use of structural funds for health care development in Hungary for the National Development Agency. From 2012 to 2014, she worked as a healthcare research specialist for a GfK, a multinational market research company, where she was responsible for quantitative research projects in various therapeutic areas.